| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |